Depression Among Cardiothoracic Surgery Patients in Baghdad
ConditionDepression
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAl-Nahrain University
About this trial
This observational study aims to estimate the prevalence and severity of depression among patients in the Cardiothoracic Surgery Ward in Baghdad City, Iraq, using a self-administered PHQ-9 questionnaire. The main questions it aims to answer are:
What is the prevalence of depression among cardiothoracic surgery patients? How is the severity of depression distributed within this group? Are there specific environmental or demographic factors associated with higher levels of depression?
Participants will:
Fill out the PHQ-9 in order to measure the severity of depressive symptoms at a specific moment in time.
Demographic and clinical variables such as age, gender, socioeconomic status, surgery type, comorbidities, and hospital stay length should be taken to look for a possible relationship with depression.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients admitted to the cardiothoracic surgery ward.
Patients who are able to understand and provide informed consent.
Patients who have the cognitive ability to complete the PHQ-9 questionnaire.
Disqualifiers
Patients with a history of diagnosed psychiatric disorders other than depression.
Patients who are critically ill or in a life-threatening condition and unable to participate.
Patients who are unable to understand the PHQ-9 questionnaire due to language or cognitive barriers.
Trial population
The study population will consist of adult patients (18 years and older) admitted to the cardiothoracic surgery ward at Al-Kadhimiya Teaching Hospital in Baghdad.
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Prevalence of Depression
Proportion of cardiothoracic surgery patients at Al-Kadhimiya Teaching Hospital who exhibit depressive symptoms.
Time frame
Data collection will occur over a 3-months period, with each participant completing the PHQ-9 assessment at a single point during this time frame.2
Severity of Depression
The severity of depression in this study will be determined based on the scores obtained from the Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 categorizes depression severity as follows: Minimal depression: Scores 0-4, indicating little to no symptoms. Mild depression: Scores 5-9, suggesting occasional symptoms that may not significantly affect daily functioning. Moderate depression: Scores 10-14, indicating more frequent symptoms that can interfere with daily life. Moderately severe depression: Scores 15-19, showing pronounced symptoms that significantly impact daily activities. Severe depression: Scores 20-27, with symptoms that are debilitating.
Time frame
Data collection will occur over a 3-months period, with each participant completing the PHQ-9 assessment at a single point during this time frame.3
Patient Health Questionnaire-9 (PHQ-9)
The total score can range from 0 to 27. Higher scores indicate greater severity of depression.
Time frame
Data collection will occur over a 3-months period, with each participant completing the PHQ-9 assessment at a single point during this time frame.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: